REGENHU announces its participation in the FLAMIN-GO project which aims to develop “personalized” treatments for rheumatoid arthritis
Researchers are developing a portable EKG device that identifies patients at risk of sudden cardiac death
Johnson & Johnson one-dose vaccine effective against COVID-19, less so against South African variants